Hints and tips:
Related Special Reports
...AstraZeneca makes 40 per cent of its sales in the US, like many European pharmaceutical companies, and it has sought to justify the increases by comparing Soriot’s pay with US pharma bosses....
...Soriot already earns more than bosses of larger European pharmaceutical companies....
...John Crowley, Bio’s newly appointed chief executive who used WuXi’s services when he ran Amicus Therapeutics, said the US pharmaceutical sector would “take years to extract ourselves from China, as it is...
...john.thornhill@ft.com...
...Like many European pharmaceutical companies, it makes a large proportion of sales in the US....
...Shah Capital now owns 6.7 per cent of Novavax, having first bought into the company in the last quarter of 2022....
...Five more top stories 1....
...For that reason, the 2023 FT Person of the Year went to Lars Fruergaard Jørgensen, chief executive of Novo Nordisk, the pharmaceutical company that brought these successful weight-loss drugs to market....
...And yet, over that same 40-year period, the average birth rate across these countries has fallen from 1.85 to 1.53....
...John Wood Group, the FTSE 250 engineering services company, should either move its listing to the US or consider going private, said activist investor Sparta Capital Management....
...Pre-tax profits at the John Lewis Partnership were £56mn in the year to January, compared with a £234mn loss the previous year. Sales climbed 1 per cent to £12.4bn....
...Bayer paid a dividend of €2.40 for 2022. Analysts had expected Bayer to pay a dividend of €1.92 per share for 2023, a far more modest cut....
...This month Brazil started distributing a vaccine produced by Japanese pharmaceutical group Takeda....
...The deal comes as pharmaceutical companies are gathered in San Francisco for an annual industry conference this week, with GSK rivals Johnson & Johnson striking a $2bn deal to acquire an oncology biotech...
...Germany’s Dax dropped 0.3 per cent, while France’s Cac 40 fell 0.4 per cent after the government cut its 2024 gross domestic product growth forecast from 1.4 per cent to 1 per cent....
...The deal comes as pharmaceutical companies gather in San Francisco for an annual industry conference, with GSK rivals Johnson & Johnson, Novartis and Merck announcing acquisitions on Monday....
...In the US, more than 40 per cent of adults are considered obese. This new class of weight loss drugs — known as GLP-1 — need to be taken consistently for lasting results....
...Other companies are developing therapies based on Crispr, which is based on the bacterial immune system....
...Lilly’s shares were up 1 per cent in New York on Wednesday....
...Pharmaceuticals companies are using AI to identify new molecules as targets for possible anticancer drugs....
...Europe has meanwhile increased its defence spending from 1.3 per cent to 1.6 per cent of GDP over the same five-year period....
...First commercialised by Danish insulin maker NovoNordisk, they are now being developed and rolled out by many major pharmaceutical companies....
...On Thursday, Sunnova priced $244mn of solar notes, its first with the DoE’s partial guarantees....
...On the back of this success, the company raised $1.1bn in a follow-on offering, the largest of its kind in the biotech sector last year according to research firm Dealogic....
...It’s the John Lewis model. The customer-owned utility....
International Edition